Female Fistula Repair

Female genitourinary fistula repair is organized by the tract involved (vesicovaginal, ureterovaginal, urethrovaginal, vesicouterine, rectovaginal) and by the surgical approach that accesses it best. The recurring decisions are route (transvaginal vs. transabdominal vs. combined), timing (immediate vs. early vs. delayed), interposition flap need (none vs. Martius vs. gracilis vs. omentum), and whether a protective diversion is required.

---

Decision Framework

In developed countries, female GU fistulas are predominantly iatrogenic — hysterectomy is the leading cause (58–66%), followed by other pelvic surgery (26%) and obstetric injury (12%). In low- and middle-income countries, prolonged obstructed labor remains the dominant etiology (Wall 2006). The four pathophysiologic factors that prevent spontaneous closure — distal obstruction, foreign body, granuloma, and tract epithelialization — make conservative management successful only in a narrow window of small, fresh, simple fistulas. Transvaginal repair is the preferred default when accessible, with the Latzko partial colpocleisis and Sims-Simon multi-layered closure as the workhorse vaginal techniques (89–100% primary success in non-irradiated VVF). Transabdominal repair (open, laparoscopic, or robotic O'Conor) is reserved for high / inaccessible fistulas, those near the ureteral orifices requiring reimplantation, complex radiation fistulas requiring vascularized abdominal flaps, or failed transvaginal repair. Tissue interposition is unnecessary for most simple non-irradiated fistulas (closure >90% without flap) but essential for radiation, recurrent, or significant-tissue-loss fistulas.

Identify the Fistula Type

Presentation	Most Likely Fistula	Key Diagnostic Test
Continuous urinary leakage per vagina + positive bladder dye test	VVF (vesicovaginal)	Cystoscopy + dye test
Continuous urinary leakage + negative bladder dye test + hydronephrosis / flank pain	UretVF (ureterovaginal)	CT urogram; retrograde pyelogram
Urinary leakage worsened by Valsalva + periurethral defect	UVF (urethrovaginal)	Cystourethroscopy; EUA with metal sound
Cyclical hematuria (menouria) ± amenorrhea after C-section	VUF (vesicouterine; Youssef syndrome)	Hysteroscopy with dye; cystoscopy; MRI
Passage of flatus / stool per vagina + foul vaginal discharge	RVF (rectovaginal)	Anoscopy; endoanal US or MRI; EUA
Continuous urinary ± fecal leakage after prolonged obstructed labor (LMIC setting)	Obstetric fistula (VVF ± RVF ± urethral damage)	Pelvic exam; Goh classification; cystoscopy

Conservative Management Where Appropriate

Fistula	Conservative Option	Selection Criteria	Expected Success
VVF	Foley catheter drainage 2–6 wk	Small (< 5 mm), fresh, simple, non-irradiated	Minority; uncertain
VVF	Endoscopic fulguration (Bugbee electrode) + 2–3 wk Foley	≤ 3.5–7 mm epithelialized tract	73–80%
UretVF	Ureteral stent × 6 wk (AUA Urotrauma 2020 — first-line)	Stent-passable lesion; retrograde or antegrade access	64–100%
VUF	Foley drainage ± hormonal suppression (GnRH-a)	Small (< 5 mm), early diagnosis	Limited data; case reports
UVF	Not typically amenable to conservative management	—	—

Surgical Decision-Making by Fistula Type

Clinical Scenario	Recommended Approach	Technique	Success Rate
Simple post-hysterectomy VVF, non-irradiated	Transvaginal (preferred)	Latzko partial colpocleisis or Sims-Simon multi-layered; ± Martius flap	89–100%
VVF near ureteral orifices, high, or inaccessible	Transabdominal	O'Conor transvesical (open / laparoscopic / robotic) ± omental interposition	91–100%
Radiation-induced VVF (RVVF)	Individualized	Vaginal + Martius; or abdominal + omental / rectus abdominis flap; 70% may require urinary diversion	20–48% primary; 80% cumulative
Recurrent VVF after failed repair	Repeat vaginal acceptable; consider abdominal if vaginal failed	Add tissue interposition if not used initially	72–83% secondary
Trigonal VVF	Transabdominal preferred	Transvesical with ureteral reimplantation if needed	~68%
UretVF, stent placement feasible	Endoscopic (first-line)	Retrograde JJ stent × 6 wk	64–100%
UretVF, stent failure	Surgical reconstruction	Ureteroneocystostomy ± psoas hitch / Boari flap (open / robotic)	~100%
UVF	Transvaginal layered repair ± Martius flap	Multi-layered closure; labial pedicle flap urethroplasty for complex cases with stricture	90–100% primary; 52% develop post-repair SUI
VUF (Youssef syndrome)	Transabdominal (open / robotic / laparoscopic) — or transvaginal	Fistula excision; double-layer bladder closure; uterine-sparing when fertility desired	100% first attempt
Obstetric VVF, Goh Type 1–2	Transvaginal layered repair	Tension-free, watertight; 14-day catheter drainage	83–88% first attempt
Obstetric VVF, Goh Type 3–4 (urethral involvement, circumferential)	Transvaginal + tissue interposition (Martius) ± urethroplasty	Adjuncts (PRP, SIS, buccal graft) for severe cases; counsel re: post-repair SUI	Lower; staged approach common
Post-obstetric persistent SUI after closure	Bulking → pubovaginal sling	Bulkamid (72%) → autologous PVS (91%)	16–55% develop persistent SUI

RVF Decision Algorithm

Clinical Scenario	Recommended Intervention	Key Considerations
Acute obstetric RVF	Nonoperative management 3–6 mo (sitz baths, fiber, wound care)	52–66% heal without surgery
Simple low RVF, intact sphincter	Endorectal advancement flap (ERAF)	ASCRS 2022 procedure of choice; 41–78% success; stoma not routinely needed
Low RVF + sphincter defect	ERAF + sphincteroplasty ± levatorplasty; or episioproctotomy	Sphincteroplasty improves healing to 80%; episioproctotomy 78–100%
Recurrent / complex RVF	Martius flap (first-line interposition)	65–94% success; shorter LOS than gracilis; stoma often unnecessary (Pastier 2024)
RVF after Martius failure	Gracilis muscle interposition	Pooled 64% success; longer LOS; SSI 32%; reserve as salvage
Anastomotic RVF (post-colorectal surgery)	Fecal diversion → transabdominal repair (repeat anastomosis, coloanal pull-through) or APR	37% heal with diversion alone; major procedures (gracilis, coloanal, APR) — OR 6.4 for success
Crohn's-related RVF	Medical therapy first (infliximab ± immunomodulator); seton for drainage; surgical repair only after endoscopic mucosal healing	ACG 2025: anti-TNF + advancement flap improves long-term healing; proctectomy as last resort
Radiation-induced RVF	Tissue interposition mandatory (Martius or gracilis); consider diversion	Martius 92–93% in radiation RVF; gracilis as salvage; GRECCAR delayed-coloanal for failed primary

For universal surgical principles (tension-free / watertight closure, tissue-interposition criteria, postoperative drainage, timing of repair, and the "first operation has the best chance" rule), and for the transvaginal-vs-transabdominal approach-selection cheat-sheet, see the Principles of Fistula Repair article — these apply across both sexes.

---

Treatment Database

All Fistula TypesObstetricRVFUretVFUrethrovaginalVUFVVF

41 of 41 techniques

Technique	Fistula Type	Notes
Foley Catheter Drainage (VVF)	VVF	Conservative management for **small (< 5 mm), fresh, simple, non-irradiated** VVF. Continuous Foley × 2–6 weeks may permit spontaneous closure in a minority of carefully selected cases. Often combined with antibiotics and topical estrogen.
Endoscopic Fulguration (VVF)	VVF	Cystoscopic Bugbee-electrode fulguration of the epithelialized fistula tract + 2–3 wk Foley drainage. **73–80% success** for very small fistulas (≤ 3.5–7 mm). Day-care procedure — also useful for small residual fistulas after failed open repair.
Transvaginal Latzko Repair	VVF	**Partial colpocleisis** — vaginal epithelium denuded around the fistula without excising the tract; multi-layer imbrication of surrounding fibromuscular tissue. **95–100% success** in non-irradiated post-hysterectomy VVF. Highly versatile — applicable to vault fistulas, complex fistulas, and postpartum settings.
Transvaginal Sims-Simon Multi-Layered Closure	VVF	Circumferential incision of vaginal epithelium around the fistula, wide vesicovaginal mobilization, layered bladder closure (mucosa ± muscularis / detrusor), then vaginal-wall closure. Edge-excision (freshening) remains debated. Modified Sims-Simon: **100% success in 47 consecutive cases without interposition, median OR 40 min** (recent series).
Transvaginal VVF Repair with Martius Flap	VVF	Transvaginal closure with interposed [Martius labial fat-pad flap](/docs/foundations/surgical-principles/flaps/martius) for recurrent, radiated, or complex VVFs where tissue bulk and vascularity drive the decision. Kapriniotis 2024 review: routine use **probably unnecessary for simple non-irradiated fistulas** (> 90% closure without flap) but valuable in 80–97% of complex cases.
Open / Robotic O'Conor VVF Repair	VVF	Transabdominal bivalve of the bladder through the fistula, excision of fistula tract, and layered closure with omental interposition. **EAU Robotic Urology Section consensus** recommends robotic O'Conor for supratrigonal, non-obstetric VVF (Randazzo 2020). Robotic series: **91–100% success** at median console 187 min, EBL 50 mL, LOS 1 day.
Laparoscopic VVF Repair	VVF	Laparoscopic transvesical or extravesical approach. Singh 2026 25-yr single-center experience: **96.6% first-repair success** with laparoscopic — comparable to open (94.0%) and transvaginal (94.2%).
Extravesical Transabdominal VVF Repair	VVF	Dissection of the vesicovaginal space without cystotomy. Less invasive, minimizes bladder tissue loss. Increasingly used with laparoscopic / robotic assistance as an alternative to the transvesical O'Conor approach.
Omental Flap Interposition (VVF)	VVF	Pedicled [omental flap](/docs/foundations/surgical-principles/flaps/omental) — most common abdominal interposition. Used for large fistulas, radiation, and complex transabdominal repairs. Minor risks: postoperative pain, ileus.
Gracilis Muscle Flap (VVF)	VVF	[Gracilis transposition](/docs/foundations/surgical-principles/flaps/gracilis) for VVFs with significant tissue loss or radiation. Donor-site morbidity; technically demanding. More commonly used for RVF and RUF in male patients.
Peritoneal Flap Interposition	VVF	[Peritoneal flap](/docs/foundations/surgical-principles/flaps/peritoneal) as an alternative to omentum during transabdominal / laparoscopic / robotic repair. Less robust blood supply but readily available without additional dissection.
Rectus Abdominis Flap (Radiation VVF)	VVF	Pedicled rectus abdominis flap based on the deep inferior epigastric vessels. Provides non-irradiated, well-vascularized tissue for radiation-induced recurrent VVF. **100% success in small series at 5–8 yr follow-up.**
Small Intestinal Graft (Salvage Radiation VVF)	VVF	Salvage technique for recurrent radiation VVF after multiple failed repairs. Complex; last resort before urinary diversion (Vaso 2015 case report).
Foley Drainage ± Hormonal Suppression (VUF)	VUF	Conservative management for **small (< 5 mm), early-diagnosis** VUF. Continuous Foley drainage; some series add GnRH-agonist hormonal suppression to halt menstrual flow during healing. Limited evidence; case reports.
Uterine-Sparing Robotic O'Conor (VUF)	VUF	Modified O'Conor for vesicouterine fistula (Youssef syndrome) preserving the uterus when fertility is desired. Intracorporeal access to the vesicouterine pouch with hysterotomy-side closure. Bonavina 2024 SR (n = 284): **100% success on first attempt** across all surgical approaches.
Hysterectomy with Bladder Repair (VUF)	VUF	Definitive VUF repair for patients not desiring uterine preservation — hysterectomy + multilayer bladder closure with omental interposition. Hysterectomy is **not routinely necessary** — uterine-sparing repair feasible with 23 reported live births post-repair (Bonavina 2024).
Transvaginal VUF Repair	VUF	Layered transvaginal repair in prone jackknife position. Feasible and effective in experienced urogynecologists' hands; 2–3.5 yr durability reported.
Ureteral Stent (UretVF) — First-Line	UretVF	**AUA Urotrauma 2020 first-line** for ureterovaginal fistula. Retrograde JJ stent attempted first; if retrograde fails, antegrade percutaneous nephrostomy + antegrade stent. Stent × 6 wk; **64–100% success**. Rabani 2021 — retrograde stent successful in 6/8 (75%) post-cesarean UretVF; all resolved at 3 mo with no stricture.
Ureteroneocystostomy ± Psoas Hitch (UretVF)	UretVF	Definitive [reimplantation](/docs/surgical-techniques/04d-upper-tract-reconstruction/ureteral-reimplantation) when stent fails. Open / laparoscopic / robotic; extravesical (Lich-Gregoir) most common for MIS. Linder 2018 robotic series: **100% success at 29.3 mo**. Kidd 2021 multi-institutional: 100% success, 1-day LOS.
Boari Flap (UretVF)	UretVF	[Boari tubularized bladder flap](/docs/surgical-techniques/04d-upper-tract-reconstruction/boari-flap-psoas-hitch) for distal ureteral defects too long for direct reimplantation + psoas hitch. Bridges defects up to 8–12 cm. Avoid in radiated bladder.
Ureteroureterostomy (UretVF)	UretVF	End-to-end ureteral anastomosis for mid-ureteral UretVF with adequate proximal and distal length. Performed in 17% of robotic UretVF repairs (Kidd 2021).
Transureteroureterostomy (UretVF)	UretVF	Anastomosis of injured ureter to contralateral healthy ureter. Reserved for cases where ipsilateral reconstruction is not feasible. Avoid if contralateral disease, stones, or urothelial carcinoma.
Transvaginal Layered UVF Repair	Urethrovaginal	Excision of fistula tract + multi-layer tension-free closure of urethra + separate vaginal-wall closure. Preferred approach. **90–100% primary success**; up to **52% develop post-repair SUI** due to sphincteric damage — counsel patients re: staged anti-incontinence procedure (synthetic / autologous sling cures 59% / improves 32%).
Latzko + Martius Flap (UVF)	Urethrovaginal	Latzko technique with [Martius bulbocavernosus flap](/docs/foundations/surgical-principles/flaps/martius) interposition for mid-urethral fistulas where periurethral tissue is scarce. Provides well-vascularized tissue to reinforce the repair (Zilberlicht 2016).
Labial Pedicle Flap Urethroplasty (Complex UVF)	Urethrovaginal	Labial skin flap reconstruction of the urethra + simultaneous fistula closure for complex UVF associated with urethral stricture. Xu 2013 series (n = 44): **93% anatomical / 91% functional success**.
Nonoperative Management (Obstetric RVF)	RVF	Sitz baths, fiber, wound care, antibiotics for infection, stool-bulking × 3–6 months. **52–66% healing** for obstetric RVF (ASCRS 2022 Recommendation 12 Grade 2C). May also be considered for other benign minimally symptomatic fistulas.
Draining Seton (RVF)	RVF	Facilitates resolution of acute inflammation / infection; useful for narrow fistulas, small vaginal openings, or multiple tracts. Long-term symptomatic relief for poor surgical candidates (ASCRS 2022 Recommendation 13 Grade 1C).
Medical Therapy for Crohn's RVF	RVF	[Infliximab](/docs/foundations/pharmacology/legacy-low-evidence) ± immunomodulator + antibiotics + seton for drainage. **ACG 2025 Strong Recommendation, Moderate Evidence**. ACCENT II trial — efficacy for RVF closure maintenance. Surgical repair only after endoscopic mucosal healing of the rectosigmoid is confirmed.
Endorectal Advancement Flap (ERAF)	RVF	**ASCRS 2022 procedure of choice** (Recommendation 14 Grade 1C). Full-thickness or partial-thickness rectal flap advanced over the fistula opening. **41–78% success** depending on etiology / technique. Failure factors: sphincter abnormalities, Crohn's, prior radiation, recurrent fistula.
ERAF + Sphincteroplasty	RVF	ERAF combined with overlapping anal sphincteroplasty ± levatorplasty when sphincter defect is present. **Improves healing to 80%** vs ERAF alone (41%).
Episioproctotomy	RVF	Transperineal division of anterior anal sphincter complex + rectovaginal septum, then layered repair. **78–100% healing**; postoperative fecal incontinence rare (~8%). ASCRS 2022 Recommendation 15 Grade 1C — for **obstetric or cryptoglandular RVF with sphincter defects**.
Transvaginal RVF Repair	RVF	Vaginal advancement flap or layered closure from the vaginal side. Used in 17% of procedures in large series; preferred by some urogynecologists. Best for low, non-irradiated, uninflamed RVF.
Martius Flap Interposition (RVF)	RVF	**First-line interposition** per ASCRS 2022 Recommendation 16. **65–94% per-procedure / 69% per-patient success at 23 mo** (Pastier 2024 — equivalent to gracilis with shorter LOS, similar morbidity, **option to avoid stoma** in 27% with no impact on outcome). Smoking is the only negative predictor.
Gracilis Muscle Interposition (RVF — Salvage)	RVF	Reserve as **salvage after Martius failure** (Pastier 2024). Pooled 64% success (range 33–100%); 59% in reoperative series. Longer LOS, higher complication rate (28–47%), 32% donor-site SSI; stoma formation associated with improved outcomes.
Fecal Diversion Alone (RVF)	RVF	Diverting loop ileostomy or colostomy. **37% heal with diversion alone** in anastomotic RVF series. Used when active inflammation or sepsis precludes definitive repair, or as a temporizing measure.
Repeat Coloanal Anastomosis / Pull-Through (GRECCAR)	RVF	Transabdominal redo coloanal anastomosis ± delayed colonic pull-through for **anastomotic RVF post-colorectal surgery** (ASCRS 2022 Recommendation 17 Grade 1C). Major procedures (gracilis, coloanal, APR) — independently associated with success (OR 6.4; Corte 2015).
Abdominoperineal Resection (APR — RVF)	RVF	Last resort for intractable RVF disease — typically radiation-induced or refractory Crohn's. Permanent colostomy. Reserve for failed all-other-options scenarios.
Obstetric VVF Repair (Goh / Waaldijk Classification)	Obstetric	Classification-driven transvaginal repair of obstructed-labour-injury-complex fistulas. **Goh classification preferred** (uses fixed external-meatus reference; superior prognostic accuracy vs Waaldijk; predicts post-closure incontinence). Fistula Foundation **87% success across 24,568 repairs**; Mourad 2026 16-yr multinational (n = 1,185, 12 countries) — 82% closure; primary 85% / simple 91%.
Panzi Score (Complex Obstetric Severity)	Obstetric	Composite 0–3 score (Mukwege 2018) derived from Goh + Waaldijk: circumferential defect + proximity to urethra + size. **Each 1-point increase → 1.65× failure odds** (p < 0.001). Parsimonious operative-decision aid for circumferential / extensive injury.
POFRI Procedure (FIGO 2025)	Obstetric	**Post-Obstetric-Fistula Residual-Incontinence (POFRI)** procedure per FIGO 2025 expert opinion. For patients with closed fistulas but **persistent SUI (16–55%)** after successful closure. Most have stress-predominant urodynamics (67% SUI, 47% urge, 47% mixed; Nardos 2022).
Adjuncts (PRP / SIS / Buccal Graft)	Obstetric	Adjunctive therapies for complex circumferential or recurrent obstetric fistulas: platelet-rich plasma, small intestinal submucosa, and buccal mucosal grafts. Emerging data; reserve for cases with extensive tissue loss after multiple failed repairs.